Investing in Psychedelics, the New Cannabis | JR Rahn

As investors begin to warm to cannabis stocks, this medicine biotech company introduces a different drug to the market: psychedelics. Founder JR Rahn joins Daniela Cambone to talk about MindMed— a leading biotech company that discovers, develops, and deploys psychedelic-inspired medicines to address addiction and mental illness.

Get the same kind of tools used by the world’s elite investors today:
https://stansberryinvestor.com/
______________________________

Follow us on Facebook: https://www.facebook.com/StansberryResearch
Follow us on Twitter: https://twitter.com/stansberry
Follow us on Instagram: https://www.instagram.com/stansberry_research
Follow us on LinkedIn: https://www.linkedin.com/company/stanberry-research

source